Hereditary angioedema with an acute attack resolved after bone marrow transplantation for acute myeloid leukemia: a case report
Abstract Background Hereditary angioedema (HAE), which is caused by C1-inhibitor (C1-INH) deficiency or dysfunction, is a rare and potentially life-threatening disease. In patients with HAE, excess production of bradykinin causes acute unpredictable recurrent attacks of angioedema in localized regio...
Main Authors: | Daisuke Honda, Isao Ohsawa, Masashi Aizawa, Yasuhiko Tomino, Katsuhiko Asanuma |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | Allergy, Asthma & Clinical Immunology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13223-023-00803-5 |
Similar Items
-
Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks
by: Michihiro Hide, et al.
Published: (2021-01-01) -
Clinical and Laboratory Characteristics That Differentiate Hereditary Angioedema in 72 Patients with Angioedema
by: Isao Ohsawa, et al.
Published: (2014-01-01) -
The diagnosis and treatment of hereditary angioedema patients in Japan: A patient reported outcome survey
by: Kazumasa Iwamoto, et al.
Published: (2021-04-01) -
Hereditary angioedema
by: Helen Lesser, et al.
Published: (2021-07-01) -
Diminished capacity of opsonization and immune complex solubilization, and detection of anti-C1q antibodies in sera from patients with hereditary angioedema
by: Daisuke Honda, et al.
Published: (2017-10-01)